Newly Approved Drug Therapies (304): Asacol (mesalamine), Procter & Gamble

Description of Medical Areas

About the FDA Approved Listings

Drugs Approved by the FDA

Drug Name: Asacol (mesalamine)

The following information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Company: Procter & Gamble
Approval Status: Approved August 1997
Treatment for: ulcerative colitits

General Information

Asacol (mesalamine) was approved by the Food and Drug Administration in August 1997. Asacol tablets are indicated for the treatment of mildly to moderately active ulcerative colitis and for the maintenance of remission of ulcerative colitis.

Side Effects

Side effects include headaches, abdominal pain, eructation, and nausea.

Back to Drug Listing

Drug listing last updated on June 20, 2008

Patient Resources: [ Trial Listing ] [ Notification Services ] [ Drug Directories ]
[ About Clinical Research ] [ Patient Resources ] [ Patient Bookstore ]
Professional Resources: [ Research Center Profiles ] [ Industry Provider Profiles ] [ Jobs in Clinical Research ]
[ Industry News ] [ Professional Resources ] [ Professional Bookstore ]
General: [ Search ] [ Site Map ] [ Your Privacy ] [ CW World ] [ Home ]